| Literature DB >> 25803815 |
Maria Tseroni1, Danai Pervanidou2, Persefoni Tserkezou3, George Rachiotis3, Ourania Pinaka3, Agoritsa Baka2, Theano Georgakopoulou2, Annita Vakali2, Martha Dionysopoulou4, Irene Terzaki2, Andriani Marka3, Marios Detsis2, Zafiroula Evlampidou5, Anastasia Mpimpa6, Evdokia Vassalou6, Sotirios Tsiodras2, Athanasios Tsakris7, Jenny Kremastinou2, Christos Hadjichristodoulou3.
Abstract
Greece, a malaria-free country since 1974, has experienced re-emergence of Plasmodium vivax autochthonous malaria cases in some agriculture areas over the last three years. In early 2012, an integrated control programme (MALWEST Project) was launched in order to prevent re-establishment of the disease. In the context of this project, the rapid diagnostic tests (RDT) of SD Bioline Malaria Ag Pf/Pan that detects hrp-2 and pan-LDH antigens were used. The aim of this study was to assess the field application of the RDT for the P. vivax diagnosis in comparison to light microscopy and polymerase chain reaction (PCR). A total of 955 samples were tested with all three diagnostic tools. Agreement of RDT against microscopy and PCR for the diagnosis of P. vivax was satisfactory (K value: 0.849 and 0.976, respectively). The sensitivity, specificity and positive predictive value of RDT against PCR was 95.6% (95% C.I.: 84.8-99.3), 100% (95% C.I.: 99.6-100.0) and 100% (95% CI: 91.7-100.0) respectively, while the sensitivity, specificity and positive predictive value of RDT against microscopic examination was 97.4% (95% C.I.: 86.1-99.6), 99.4% (95% C.I.: 98.6-99.8) and 86.1% (95% CI: 72.1-94.7), respectively. Our results indicate that RDT performed satisfactory in a non-endemic country and therefore is recommended for malaria diagnosis, especially in areas where health professionals lack experience on light microscopy.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25803815 PMCID: PMC4372373 DOI: 10.1371/journal.pone.0120367
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flow chart of all samples collected for malaria in Greece (2012).
Description of samples included in the analysis.
| Number of samples | Data for study population | Immigrants | Greek population |
|---|---|---|---|
|
| Samples distribution | 909 | 46 |
| Mean age | Mean age: 26.7 years old (range: 3–67) | Mean age: 27.0 years old (range: 1–91) | |
| Country of origin | Pakistan: 830/909 (91.3%), Afghanistan: 37/909 (4.1%), Bangladesh: 15/909 (1.7%), India: 11/909 (1.2%), Romania: 10/909 (1.0%), Morocco: 6/909 (0.7%) | Greece | |
| Duration of stay in Greece | Recorded for 635/909, mean duration of stay: 33.9 months (range: 1–264 months) | N/A | |
|
| Samples distribution | 75 | 18 |
| Mean age | Mean age: 26.5 years old (range: 10–49) | Mean age: 49.2 years old (range: 2.5–91) | |
| Country of origin | Pakistan: 68/75 (90.7%), Afghanistan: 4/75 (5.4%), Bangladesh: 1/75 (1.3%), Romania: 1/75 (1.3%), Morocco: 1/75 (1.3%) | Greece | |
| Duration of stay in Greece | Recorded for 36/75, mean duration of stay: 33.4 months (range: 3.5–60 months) | N/A | |
|
| Samples distribution | 34 | 11 |
| Mean age (45 PCR positive samples) | Mean age: 23.8 years old (range: 10–49) | Mean age: 50.5 years old (range: 23–82) | |
| Country of origin | Pakistan: 21/34 (61.8%), Afghanistan: 9/34 (26.5%), Bangladesh: 2/34 (5.9%), Romania: 1/34 (2.9%), Morocco: 1/34 (2.9%) | Greece | |
| Duration of stay in Greece | Recorded for 31/34, mean duration of stay: 32.4 months (range: 5–60 months) | N/A |
RDT and PCR results of samples for P. vivax.
| PCR | ||||
|---|---|---|---|---|
| Positive | Negative | Total | ||
|
|
| 43 | 0 | 43 |
|
| 2 | 910 | 912 | |
|
| 45 | 910 | 955 | |
Microscopy and PCR results of samples for P. vivax.
| PCR | ||||
|---|---|---|---|---|
| Positive | Negative | Total | ||
|
|
| 38 | 0 | 38 |
|
| 7 | 910 | 917 | |
|
| 45 | 910 | 955 | |
RDT and microscopy results for P. vivax.
| Microscopy | ||||
|---|---|---|---|---|
| Positive | Negative | Total | ||
|
|
| 37 | 6 | 43 |
|
| 1 | 911 | 912 | |
|
| 38 | 917 | 955 | |